Professional Documents
Culture Documents
The program has been designed to allow the attendees time to interact with
our corporate sponsors, and for attendees to network in an engaging setting.
Gold
sponsor:
Bronze
sponsor:
Other
sponsor:
2
Meeting Place
Room 15-C
Marye Anne Fox Executive Conference Room Room 15-B Room 15-A
Emergency Exit
Projector Screen
Credenza
Emergency Exit
Credenza
Men’s Ladies
Lobby Restroom Restroom Pantry Storage
Elevators
Credenza
Emergency Exit
Scholar Dr N
3
Program
4
12:30 pm: Lunch (Room 15-B, Patio)
1:30 pm: Afternoon session 1: Personalized medicine: which device is best for
your patient? (Room 15-A)
Chair: Rui C. Sá (La Jolla CA/US)
1:30pm: Personalized medicine: which device is best for your patient?
Arzu Ari (San Marcos, TX/US)
1:55pm: Justification of the Inhalation Parameters to Provide Patients with Dose
Confirmation Feedback When They Use a Digitally Enabled Albuterol
Multidose Dry Powder Inhaler (eMDPI).
Gui Safoti (Amsterdam, Netherlands)
2:10pm: Enabling Aerosol Delivery to Our Smaller Patients: Developing Drugs for
Infants
James Fink (San Mateo, CA/US)
2:25 pm: Afternoon session 2: Industry-sponsored session
Panel discussion - Can aerosol therapy benefit from digital health?
(Room 15-B)
Facilitator: Philip Kuehl (Albuquerque, NM/US)
2:25 pm: Aerosol therapy and digital health: a clinician’s perspective
Douglas J Conrad (San Diego, CA/US)
2:45 pm: Panel discussion
Sam van Alstyne (Connected Health - 3M Drug Delivery Systems)
Sai Shankar (Connected Devices, Aptar Pharma)
Douglas J Conrad (Clinician, University of California, San Diego)
3:50 pm: Poster session/ Hands-on demo (Room 15-B)
4:50 pm: Final remarks
Chantal Darquenne (La Jolla, CA/US)
5:00 pm: Reception/Networking (Patio)
7:00 pm: End of symposium
5
POSTERS
Poster 1
Preclinical Experiments Support Recent Clinical Switch to Delivered Dose During
Methacholine Bronchoprovocation Testing. O. Schmid1, W. Möller1, A. Stelzl1, J.
Lund2, A.Ö. Yildirim1, S. Krauss-Etschmann2, A. Robichaud3.
1
Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München (HMGU),
Neuherberg/Munich, Germany, 2 Research Center Borstel (RCB), Borstel, Germany, 3
SCIREQ Scientific Respiratory Equipment, Inc., Montreal, Quebec, Canada.
Poster 2
Methacholine bronchoconstriction is spatially persistent and independent of
posture during drug inhalation. E.T. Geier1, K. Kubo1, I. Neuhart2, R.J. Theilmann3,
G.K. Prisk1, R.C. Sá1
1
Department of Medicine, University of California – San Diego. 2The Ohio State
University. 3Department of Radiology, University of California – San Diego.
Poster 3
Intrapulmonary Deposition & Uptake Kinetics of Electronic Cigarette Vapor Imaged
with PET. Jose G. Venegas, PhD1, Jiayuan Zhao, PhD2, Gabriel Mota-Ribeiro1, Philip
Demokritou PhD2, Mikhail Papisov, PhD3.
1
Department of Anesthesia and Critical Care and Pain Medicine, Massachusetts General
Hospital and Harvard Medical School, Boston, MA, 2 Department of Environmental
Health, Center for Nanotechnology and Nanotoxicology, Harvard School of Public Health,
Boston, MA, 3Department of Radiochemistry, Massachusetts General Hospital and
Harvard Medical School, Boston, MA.
Poster 4
Justification of the Inhalation Parameters to Provide Patients with Dose
Confirmation Feedback When They Use a Digitally Enabled Albuterol Multidose Dry
Powder Inhaler (eMDPI). H. Chrystyn1, G. Safioti2, D. Buck3, F. Ruiter4, J. Blair3.
1
Inhalation Consultancy Ltd, Leeds, United Kingdom, 2Teva Pharmaceutical Industries,
Amsterdam, Netherlands, 3Teva Pharmaceutical Industries, Waterford, Ireland, 4Teva
Pharmachemie, Haarlem, Netherlands.
6
Poster 5
The Accuracy of an Electronic Multidose Dry Powder Inhaler (eMDPI) To Measure
Inhalation Parameters When Used by Patients. H. Chrystyn1, D. Saralaya2, A.
Shenoy2, S. Toor3, K. Kastango4, E. Calderon5, G. Safioti6.
1
Inhalation Consultancy Ltd, Leeds, United Kingdom, 2Bradford Teaching Hospitals NHS
Foundation Trust & Bradford Institute for Health Research, Bradford, United Kingdom,
3
Respiratory Matters, Huddersfield, United Kingdom, 4QuintilesIMS, Cambridge, MA,
United States, 5Teva Pharmaceutical Industries, Waterford, Ireland, 6Teva
Pharmaceutical Industries, Amsterdam, Netherlands.
Poster 6
i-BAN, a unique breath-actuated, small volume, jet nebulizer vs AE II: aerosol
characterization in continuous and breath-actuated mode. Rohinton Toddywala1,
Vijay Shukla1, Akanksha Hande1, Michael Newhouse2.
InspiRx Inc., Somerset NJ, 2McMaster, Faculty of Health Sciences, Hamilton, Canada
1
Poster 7
Compliance with Once-Daily Inhaled Liposomal Ciprofloxacin (ARD-3150) therapy
in Non-cystic Fibrosis Bronchiectasis. Angela Davis1, Igor Gonda2, Juergen
Froehlich2, David Cipolla2.
1
Grifols, Research Triangle Park, NC, 2Aradigm Corporation, Hayward, CA.
Poster 8
Formulation and non-clinical assessment of a novel dry powder formulation of
Topotecan for targeted treatment of lung cancer. Philip J. Kuehl, Michael Burke,
Ramesh Chand, Devon Dubose, June Liu, and Mathewos Tessema.
Lovelace Biomedical, Albuquerque, NM
Poster 9
Bringing Pharmaceutical Science to the Cannabis and Industrial Hemp Industries:
Development of Dry Powders Suitable for Inhalation. Lia Rebits1 and Robert Sievers2.
1
KelSie Biotech LLC, Boulder, CO, 2Dept. of Chemistry and Biochemistry, University of
Colorado, Boulder, CO.
7
Poster 10
A Novel Approach to Controlling Particle Morphology for the Engineering of
Respirable Powders. Xuno Gildelamadrid1 and Robert Sievers2.
1
KelSie Biotech LLC, Boulder, CO, 2Dept. of Chemistry and Biochemistry, University of
Colorado, Boulder, CO.
Poster 11
Aerosol Dosimetry in Asthmatic Airways: An in-Silico Modeling Pilot Study. K.
Poorbahrami1, S. B. Fain2, D. Mummy3, J. M. Oakes4.
Mechanical and Industrial Engineering, Northeastern University, Boston, MA,
1
Departments of Medical Physics and Radiology, School of Medicine and Public Health,
2
Poster 12
Age-Dependent Deposition Patterns and Quantitative Biokinetics of Inhaled 20nm
Gold Nanoparticles in Rat Lungs. J. C. Schittny1, W. Moeller2, U. Holzwarth3, S. Hirn2,
A. Wenk2, C. Schleh2, M. Schäffler2, N. Haberl2, N. Gibson3, W. G. Kreyling2.
1
Inst of Anatomy, Univ of Bern, Bern, Switzerland, 2Institute of Lung Biology and Disease,
Helmholtz Center Munich, Neuherberg/Munich, Germany, 3Consumers and Reference
Materials, European Commission, Joint Research Centre, Directorate for Health, Ispra,
Italy.